AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| ERD SPH Notice - First NZ Capital Group Limited | |||
| 06/04/18 | |||
| ERD Market Update EROAD: Contracted Units up 61.5% for the year | |||
| 06/04/18 | PRICE SENSITIVE | ||
| ERD EROAD responds to lifting of name suppression | |||
| 19/03/18 | |||
| ERD D&O Ongoing Disclosure - Graham Stuart | |||
| 13/03/18 | |||
| ERD President’s Economic Report Outlines a Move from Fuel Tax | |||
| 12/03/18 | |||
| ERD Ongoing Disclosure Notice Michael Bushby | |||
| 08/03/18 | |||
| ERD Ongoing Disclosure Notice Candace Kinser | |||
| 08/03/18 | |||
| ERD D&O Ongoing Disclosure for Anthony Gibson | |||
| 08/03/18 | |||
| ERD EROAD Limited – SPP Allotment | |||
| 06/03/18 | |||
| ERD EROAD Share Purchase Plan oversubscription confirmed | |||
| 28/02/18 | PRICE SENSITIVE | ||
| ERD EROAD SPP successfully closes oversubscribed | |||
| 28/02/18 | PRICE SENSITIVE | ||
